Skip to main content
OSRHW
NASDAQ Industrial Applications And Services

OSR Health Q3 Sales Fall 16%, Gross Margin Collapses to 7% With $1.37M Cash

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Negative
Importance info
8
Price
$0.004
Mkt Cap
$3.512M
52W Low
$0.002
52W High
$0.105
52W Position info
68% above low
Off High info
96% below high
Rel. Volume info
3.1× avg
Market data snapshot near publication time

OSRHW sits 68% above its 52-week low of $0.002 on elevated volume (3.1× avg).

Summary

OSR Health's Q3 2026 10-Q shows sales down 16% and gross margin collapsing to about 7%, with only $1.37 million of cash against $16.7 million of current liabilities and a defaulted convertible note.


Key Events · Earnings and Guidance · OSRHW

  • Q3 Sales Down 16%, Gross Margin Collapses

    Net sales fell to $524,793 from $627,747 while cost of sales rose 33% to $486,915, cutting gross profit 86% to $37,878 — roughly a 7% gross margin versus about 42% a year earlier, blamed on RMC discounting major products.

  • Nine-Month Sales Halved, Loss Narrowed

    Nine-month net sales fell 48% to $1,324,519 after RMC lost two supplier distribution arrangements; operating loss narrowed 18% to $9,763,783 and net loss attributable to the parent was $5,394,513, or $0.16 per share.

  • Thin Liquidity Against Heavy Current Liabilities

    Cash and cash equivalents were $1,368,312 at September 30, 2026 versus $16,679,417 of current liabilities; operating cash burn was $3,792,999 for the nine months.

  • Convertible Note in Default After Delisting

    The White Lion senior secured convertible note (original principal $1,055,556, maturing January 7, 2027) is in default on Nasdaq-related triggers, allowing conversion at 90% of market price and a 120% principal demand; the holder converted $140,000 into 140,000 shares since September 30, leaving about $791,438 outstanding.


Analysis · OSRHW · Industrial Applications And Services

The quarter shows the business shrinking and the balance sheet thinning at the same time. Net sales fell 16% to $524,793 while cost of sales rose 33%, so gross profit dropped 86% to $37,878 — a roughly 7% gross margin versus about 42% a year earlier, which the company attributes to RMC discounting major products. Against $1.37 million of cash sits $16.68 million of current liabilities, and the White Lion convertible note is in default after the Nasdaq delisting, letting the holder convert at a 10% discount to VWAP and demand 120% of principal. Management also flags a bank hold of up to about $2.3 million tied to litigation and an expected $2.07 million Chardan judgment it has already conceded. The one large equity item — up to 97,913,315 Delivery Shares under the loyalty CVR program — would be massively dilutive if the price thresholds were ever met, and the authorized share increase needed to support it has been approved but not yet effected.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, OSRHW was trading at $0.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.5M. The 52-week trading range was $0.00 to $0.10. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

OSRHW - Latest Insights

OSRHW
Nov 13, 2026, 8:37 AM EST
Filing Type: 8-K
Importance Score:
8
OSRHW
Oct 28, 2026, 9:30 AM EDT
Filing Type: 8-K
Importance Score:
9
OSRHW
Oct 16, 2026, 9:17 AM EDT
Filing Type: 8-K
Importance Score:
8
OSRHW
Aug 28, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
9